Search research articles
Contact Us
Filters
Showing results (101-110 of 126) with videos related to
Page
of 13
Sort By:
Leukemia & Lymphoma
|
February 17, 2023
Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis
Wei Xu, Shenmiao Yang, Keshu Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2021
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis
Yuqin Song, Quanli Gao, Huilai Zhang, et al.
Blood
|
July 26, 2019
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
Constantine S Tam, Judith Trotman, Stephen Opat, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2026
PD-1 blockade drug holiday improves exhausted progenitor CD8 T cell (Tpex) reinvigoration by avoiding Tpex adaptive resistance
Shin Foong Ngiow, Ryan P O'Connell, Sasikanth Manne, et al.
Cell
|
August 9, 2024
LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity
Shin Foong Ngiow, Sasikanth Manne, Yinghui Jane Huang, et al.
Immunity
|
May 13, 2020
Developmental Relationships of Four Exhausted CD8<sup>+</sup> T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms
Jean-Christophe Beltra, Sasikanth Manne, Mohamed S Abdel-Hakeem, et al.
Cell
|
August 9, 2024
LAG-3 and PD-1 synergize on CD8<sup>+</sup> T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity
Lawrence P Andrews, Samuel C Butler, Jian Cui, et al.
Nature Immunology
|
October 21, 2022
Shared and distinct biological circuits in effector, memory and exhausted CD8<sup>+</sup> T cells revealed by temporal single-cell transcriptomics and epigenetics
Josephine R Giles, Shin Foong Ngiow, Sasikanth Manne, et al.
Haematologica
|
October 15, 2020
Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion
Constantine S Tam, Tadeusz Robak, Paolo Ghia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2022
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial
Peter Hillmen, Barbara Eichhorst, Jennifer R Brown, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 126) with videos related to
Sort By:
Page
of 13
Leukemia & Lymphoma
|
February 17, 2023
Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis
Wei Xu, Shenmiao Yang, Keshu Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2021
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis
Yuqin Song, Quanli Gao, Huilai Zhang, et al.
Blood
|
July 26, 2019
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
Constantine S Tam, Judith Trotman, Stephen Opat, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2026
PD-1 blockade drug holiday improves exhausted progenitor CD8 T cell (Tpex) reinvigoration by avoiding Tpex adaptive resistance
Shin Foong Ngiow, Ryan P O'Connell, Sasikanth Manne, et al.
Cell
|
August 9, 2024
LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity
Shin Foong Ngiow, Sasikanth Manne, Yinghui Jane Huang, et al.
Immunity
|
May 13, 2020
Developmental Relationships of Four Exhausted CD8<sup>+</sup> T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms
Jean-Christophe Beltra, Sasikanth Manne, Mohamed S Abdel-Hakeem, et al.
Cell
|
August 9, 2024
LAG-3 and PD-1 synergize on CD8<sup>+</sup> T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity
Lawrence P Andrews, Samuel C Butler, Jian Cui, et al.
Nature Immunology
|
October 21, 2022
Shared and distinct biological circuits in effector, memory and exhausted CD8<sup>+</sup> T cells revealed by temporal single-cell transcriptomics and epigenetics
Josephine R Giles, Shin Foong Ngiow, Sasikanth Manne, et al.
Haematologica
|
October 15, 2020
Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion
Constantine S Tam, Tadeusz Robak, Paolo Ghia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 2022
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial
Peter Hillmen, Barbara Eichhorst, Jennifer R Brown, et al.
Page
of 13